Novartis NVS announced that the FDA has approved Fabhalta (iptacopan) for a third indication. The regulatory body approved ...

In November 2024, the American College of Rheumatology (ACR) released a summary of their new guidelines for the screening, treatment, and management of lupus nephritis. What is important for a patient ...

In addition to REGENCY, Gazyva/Gazyvaro is being investigated in children and adolescents with lupus nephritis, people with membranous nephropathy, childhood-onset idiopathic nephrotic syndrome and ...

In addition to REGENCY, Gazyva is being investigated in children and adolescents with lupus nephritis, people with membranous nephropathy, childhood-onset idiopathic nephrotic syndrome and ...

In addition to the REGENCY clinical trial, Gazyva is being investigated in children and adolescents with lupus nephritis, people with membranous nephropathy, childhood-onset idiopathic nephrotic ...

In addition to REGENCY, Gazyva/Gazyvaro is being investigated in children and adolescents with lupus nephritis, people with membranous nephropathy, childhood-onset idiopathic nephrotic syndrome and ...

Besides REGENCY, Gazyva/Gazyvaro is also being investigated in children and adolescents with lupus nephritis, people with membranous nephropathy, childhood-onset idiopathic nephrotic syndrome, and ...

What is lower crossed syndrome? If you’ve been told that you have lower crossed syndrome (LCS), you might wonder what this condition is, what causes it, and how it is treated. Lower crossed ...

Barcelona cruised to a 4-0 victory against 10-man Real Sociedad to return to the top of La Liga. Victory means a one-point advantage over Atletico Madrid at the summit and leaves La Blaugrana ...

Ukraine President Volodymyr Zelensky’s trip to the Oval Office may have started on a cordial note but tensions soared within minutes when US Vice President JD Vance accused Zelensky of being ...